Shanghai OPM Biosciences (688293.SH) major shareholder China Life Gainreduces its holding by 1%.
Aopumai (688293.SH) announcement, the company's shareholder holding more than 5% of the shares, China Life Chengda (Shanghai) Health Industry equity...
Shanghai OPM Biosciences (688293.SH) announced that the shareholder China Life Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) (referred to as "China Life Chengda") reduced its holdings of the company's shares by a total of 1.1477 million shares, representing 1.00% of the total share capital of the company, through centralized auction trading from November 7, 2024 to November 15, 2024.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
